4 hours Ago By ABMN Staff
Avantor, Inc. ( NYSE:AVTR – Free Report ) – Analysts at Zacks Research decreased their Q1 2026 earnings per share estimates for shares of Avantor in a research report issued on Tuesday, December 10th. Zacks Research analyst D.
Dey now anticipates that the company will post earnings per share of $0.30 for the quarter, down from their previous forecast of $0.32.
The consensus estimate for Avantor’s current full-year earnings is $0.98 per share. Zacks Research also issued estimates for Avantor’s Q3 2026 earnings at $0.
31 EPS and FY2026 earnings at $1.26 EPS. Other analysts have also issued reports about the stock.
Robert W. Baird reduced their price target on shares of Avantor from $27.00 to $26.
00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 price target on shares of Avantor in a report on Thursday, September 26th.
UBS Group cut their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th.
Barclays lowered their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th.
Finally, Wells Fargo & Company cut their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th.
Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.
69. Avantor Price Performance Shares of Avantor stock opened at $22.33 on Thursday.
The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.
84. The stock has a market cap of $15.20 billion, a PE ratio of 48.
98, a price-to-earnings-growth ratio of 2.75 and a beta of 1.29.
Avantor has a 52 week low of $19.59 and a 52 week high of $28.00.
The company’s 50-day moving average price is $22.53 and its two-hundred day moving average price is $23.54.
Hedge Funds Weigh In On Avantor Hedge funds and other institutional investors have recently modified their holdings of the stock. Blue Trust Inc. lifted its holdings in shares of Avantor by 1,830.
3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after buying an additional 1,391 shares during the period.
UMB Bank n.a. purchased a new position in shares of Avantor in the third quarter valued at $49,000.
Nisa Investment Advisors LLC raised its position in Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares during the period.
GAMMA Investing LLC grew its holdings in Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after purchasing an additional 1,285 shares during the last quarter.
Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Avantor by 278.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock worth $130,000 after purchasing an additional 3,700 shares during the last quarter.
Hedge funds and other institutional investors own 95.08% of the company’s stock. Avantor Company Profile ( Get Free Report ) Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. Recommended Stories Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter .
.
